Skip to main content
. 2023 Jul 11;15(14):3572. doi: 10.3390/cancers15143572

Figure 2.

Figure 2

Survival of patients with primary MDSs, without induction chemotherapy or stem cell transplantation, stratified by the absolute monocyte count (<0.2 × 109/L, 0.2–0.4 × 109/L, and >0.4 × 109/L). (A) Whole cohort (n = 689); (B) IPSS-R intermediate risk (n = 258).